Home / Stocks / Quick Heal Tech Ltd
QUICKHEAL

Quick Heal Tech Ltd Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹146.75

Change

-3.17 (-2.11%)

Open

₹150.18

Prev. Close

₹149.92

Day High

₹150.25

Day Low

₹145.69

Volume Analysis

Traded

97,338

Delivered

40,693

Delivery %

41.81%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (0)

No signal for this stock

Weaknesses (4)

  • •Low return on equity (-3.82%)
  • •Promoter holding is falling
  • •Below-average fundamentals quality score (31/100)
  • •Low operating margin (-19.0%)

Opportunities (0)

No signal for this stock

Threats (1)

  • •FII holding has been falling

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹153.99 ₹152.12 ₹149.43 ₹147.56 ₹144.87 ₹143.0 ₹140.31
Fibonacci ₹152.12 ₹150.38 ₹149.3 ₹147.56 ₹145.82 ₹144.74 ₹143.0
Camarilla ₹148.0 ₹147.59 ₹147.17 ₹147.56 ₹146.33 ₹145.91 ₹145.5

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

-44.98%

1 Week

-2.2%

1 Month

+3.3%

3 Months

+2.72%

6 Months

-25.78%

1 Year

-52.84%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

DuPont ROE Breakdown

-3.4%

Net margin -5.65% × asset turnover 0.46x × equity multiplier 1.31x

Company Overview

Sector

Information Technology

Market Cap

₹796 Cr

ROE

-3.82%

Book Value

₹80.4

Face Value

₹10.0

Source: Screener.in (Consolidated figures) — data as of 19 Nov 2026. Not investment advice.

TopFund Analysis

Quick Heal Tech Ltd scores weakly on TopFund's composite fundamentals check within the Information Technology sector, at 31/100. The strongest factor is Financial Strength (100/100), while Growth (0/100) is the weakest area to weigh before deciding. Notably: Low return on equity (-3.82%); promoter holding is falling. FII holding has been falling.

TopFund Score — Fundamentals Quality

31/100 — Weak

Data confidence: 75/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

100

Growth

0

Valuation

50

Cash Flow

30

Corporate Governance

43

Momentum

11

Institutional Ownership

10

Business Quality

20

Risk & Volatility

14

Liquidity

2

From Screener.in

  • +Company is almost debt free.
  • +Company's working capital requirements have reduced from 90.4 days to 58.6 days
  • −Company has low interest coverage ratio.
  • −The company has delivered a poor sales growth of -4.76% over past five years.
  • −Company has a low return on equity of 0.67% over last 3 years.
  • −Company has high debtors of 192 days.

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Head of Seqrite Labs, Sangamesh S, resigned effective November 13, 2026.

Seqrite Labs Head Sangamesh S resigned effective November 13, 2026.

Allotment of 1,210 Equity Shares under ESOP Scheme 2021

Quick Heal released Q2 FY27 investor call transcript; revenue rose 44% QoQ to ₹65 crore, PAT ₹5.8 crore.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales + 78 82 80 70 73 71 65 57 84 72 49 45 65
Expenses + 67 70 70 68 70 74 74 67 74 71 78 63 63
Operating Profit 11 12 10 3 3 -4 -8 -10 9 0 -29 -18 2
OPM % 14.0% 14.18% 12.55% 3.68% 4.18% -5.34% -13.02% -17.0% 11.05% 0.63% -60.17% -39.05% 3.54%
Other Income + 6 4 7 5 5 5 6 6 4 9 4 14 8
Interest 0 0 0 0 0 0 0 0 0 0 0 0 1
Depreciation 3 3 3 3 3 3 4 3 3 4 4 4 6
Profit before tax 13 13 14 5 5 -2 -7 -7 10 6 -30 -7 4
Tax % 3.8% 19.71% -3.62% 16.22% 18.15% -104.76% -50.53% -21.29% 23.05% -14.96% -32.79% -27.87% -33.95%
Net Profit + 13 10 14 4 4 0 -3 -6 8 7 -20 -5 6
EPS in Rs 2 2 3 1 1 0 -1 -1 1 1 -4 -1 1
Raw PDF — — — — — — — — — — — — —
YoY Sales growth -22 23 62 37 -6 -14 -19 -19 14 1 -25 -21 -22

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 286 302 300 318 315 286 333 342 278 292 280 261 230
Expenses + 194 200 210 198 187 195 192 235 276 274 286 290 274
Operating Profit 92 102 90 120 128 92 141 107 2 18 -7 -29 -44
OPM % 32.0% 34.0% 30.0% 38.0% 41.0% 32.0% 42.0% 31.0% 0.7% 6.0% -2.4% -11.0% -19.0%
Other Income + 8 10 25 30 33 31 24 19 22 21 21 23 35
Interest 0 0 0 0 0 0 0 0 0 0 0 0 1
Depreciation 20 24 31 27 24 22 19 17 16 13 13 14 17
Profit before tax 80 88 84 123 137 101 146 109 8 26 1 -21 -27
Tax % 33.0% 34.0% 37.0% 33.0% 33.0% 27.0% 27.0% 23.0% 20.0% 8.0% -404.0% -47.0% —
Net Profit + 54 58 53 83 92 74 107 83 6 24 5 -11 -13
EPS in Rs 9 8 8 12 13 12 17 14 1 5 1 -2 -2
Dividend Payout % 85.0% 30.0% 33.0% 25.0% 15.0% 35.0% 24.0% 31.0% 207.0% 66.0% 0.0% 0.0% —
Sales growth 18 6 -1 6 -1 -9 16 3 -19 5 -4 -7 -17

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Reserves 270 559 592 653 719 580 687 570 367 383 387 382 382
Borrowings + 0 0 0 0 0 0 0 0 0 0 0 0 30
Other Liabilities + 97 88 72 57 63 52 75 88 74 76 83 110 103
Total Liabilities 428 717 734 781 853 697 827 716 493 513 525 547 569
Fixed Assets + 111 142 185 173 165 158 146 137 124 117 119 122 149
CWIP 74 55 14 14 11 3 2 0 0 3 0 0 1
Investments 130 115 182 306 390 310 416 318 198 190 179 213 264
Other Assets + 113 405 353 287 288 225 263 261 171 203 226 212 155
Total Assets 428 717 734 781 853 697 827 716 493 513 525 547 569
Equity Capital 61 70 70 70 71 64 64 58 53 54 54 54 54

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 77 78 36 94 61 71 99 80 31 18 -22 15
Cash from Investing Activity + -53 -163 -73 -122 -37 148 -92 126 185 6 16 -26
Cash from Financing Activity + -18 189 -20 -19 -24 -221 0 -214 -212 2 -10 3
Net Cash Flow 7 104 -57 -47 1 -3 6 -9 4 26 -17 -8
Free Cash Flow 11 42 2 80 54 60 90 79 32 12 -36 6
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 116 92 73 100 91 114 90 106 2,064 102 325 -80

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 72.76% → 71.46%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Public 24.13% 23.81% 23.61% 23.68% 23.42% 23.52% 24.46% 25.53% 25.73% 26.62% 28.08% 28.16%
Promoters 72.76% 72.48% 72.44% 72.08% 71.92% 71.82% 71.79% 71.63% 71.54% 71.5% 71.48% 71.46%
FII 1.66% 1.65% 1.54% 1.61% 1.81% 2.03% 1.16% 0.5% 0.45% 0.73% 0.46% 0.4%
DII 1.44% 2.06% 2.41% 2.62% 2.84% 2.63% 2.58% 2.33% 2.29% 1.16% 0.0% 0.0%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Information Technology — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Quick Heal Tech Ltd (this stock) 796 — 1.83 -3.82%
Srit India Limited 812 17.3 — 30.2%
Excelsoft Technologies L 847 17.8 1.42 9.85%
Onward Technologies Ltd. 851 17.1 3.44 19.5%
TVS Electronics Ltd 730 74.2 8.39 11.6%
Digitide Solutions Ltd 911 360.0 1.08 -0.74%
Xchanging Solutions Ltd 667 11.2 1.61 15.8%

Which Mutual Funds Hold Quick Heal Tech Ltd?

Frequently Asked Questions about Quick Heal Tech Ltd

Community Sentiment

What are other investors saying about Quick Heal Tech Ltd?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.